CEO of Biomarin Pharmaceutical, Inc. (BMRN) Jean Jacques Bienaime sells 9,000 shares of BMRN on 12/21/2012 at an average price of $48.57 a share.

Biomarin Pharmaceutical, Inc. has a market cap of $6.15 billion; its shares were traded at around $48.9 with and P/S ratio of 13.2.

This is the annual revenues and earnings per share of BMRN over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of BMRN.

CEO Recent Trades:

• CEO Jean Jacques Bienaime sold 9,000 shares of BMRN stock on 12/21/2012 at the average price of 48.57. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 0.68% since.
• CEO Jean Jacques Bienaime sold 5,000 shares of BMRN stock on 12/12/2012 at the average price of 50. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has decreased by 2.2% since.
• CEO Jean Jacques Bienaime sold 6,000 shares of BMRN stock on 12/10/2012 at the average price of 47.53. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 2.88% since.
• CEO Jean Jacques Bienaime sold 5,000 shares of BMRN stock on 12/04/2012 at the average price of 47.94. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 2% since.
• CEO Jean Jacques Bienaime sold 8,000 shares of BMRN stock on 11/16/2012 at the average price of 48.05. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 1.77% since.

This is the insider trade history vs. stock price of BMRN. For the complete insider trading history of BMRN, click here.

Directors and Officers Recent Trades:

• VP, Human Resources Mark Wood sold 10,415 shares of BMRN stock on 12/17/2012 at the average price of 49.17. Mark Wood owns at least 25,646 shares after this. The price of the stock has decreased by 0.55% since.
• Director Richard A Meier sold 5,000 shares of BMRN stock on 12/11/2012 at the average price of 49.71. Richard A Meier owns at least 18,650 shares after this. The price of the stock has decreased by 1.63% since.
• Director Richard A Meier sold 5,000 shares of BMRN stock on 11/29/2012 at the average price of 49.17. Richard A Meier owns at least 18,650 shares after this. The price of the stock has decreased by 0.55% since.
• SVP, Chief Commercial Of Jeffrey Robert Ajer sold 5,916 shares of BMRN stock on 11/28/2012 at the average price of 48.31. Jeffrey Robert Ajer owns at least 10,570 shares after this. The price of the stock has increased by 1.22% since.
• VP, Human Resources Mark Wood sold 2,665 shares of BMRN stock on 11/23/2012 at the average price of 48.92. Mark Wood owns at least 32,364 shares after this. The price of the stock has decreased by 0.04% since.

For the complete insider trading history of BMRN, click here.

Why CEOs Are Buying Stocks Of Their Own Companies?

1. As legendary investor Peter Lynch said: "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise."
2. TOP EXECUTIVES like CEOs and CFOs are savvy buyers of their companies' shares. One long-term study showed that they beat the market on average by six percentage points a year.
3. Another study found that the aggregated activities of insiders can serve as a good indicator to locate market bottoms. Insiders as a whole are smart investors of their own companies.

Click it to Check Out What the CEO Are Trading

More Gurufocus Links

Latest Guru Picks	Value Strategies
Warren Buffett Portfolio	Ben Graham Net-Net
Real Time Picks	Buffett-Munger Screener
Aggregated Portfolio	Undervalued Predictable
ETFs, Options	Low P/S Companies
Insider Trends	10-Year Financials
52-Week Lows	Interactive Charts
Model Portfolios	DCF Calculator
RSS Feed	Monthly Newsletters
The All-In-One Screener	Portfolio Tracking Tool